Location
The broadest mission of these Conferences is collective pursuit of understanding of the issues surrounding early diagnosis and early treatment of lung cancer. Given the announcement by the National Cancer Institute on the National Lung Screening Trial (NLST) that CT screening for lung cancer significantly reduces mortality in high-risk participants, the focus of this meeting is continued updating of an optimal regimen of screening to reduce the potential harms and cost of screening and the continued development of clinical trials to assess treatment alternatives for early lung cancer. The International Lung Cancer Consortium (ILCCO) and International Early Lung Cancer Action Program (I-ELCAP) are holding joint sessions on Friday and Saturday morning.
